Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex
about
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Neurobiology of anorexia and bulimia nervosaA 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey modelHow Does the Brain Implement Adaptive Decision Making to Eat?Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor LigandsCurrent status of functional imaging in eating disordersIdentifying serotonergic mechanisms underlying the corticolimbic response to threat in humansNothing tastes as good as skinny feels: the neurobiology of anorexia nervosaRecent advances in the neuropsychopharmacology of serotonergic hallucinogensCentral serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?The native serotonin 5-HT(5A) receptor: electrophysiological characterization in rodent cortex and 5-HT(1A)-mediated compensatory plasticity in the knock-out mouseDopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptorsThe activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activityWomen with multiple chemical sensitivity have increased harm avoidance and reduced 5-HT(1A) receptor binding potential in the anterior cingulate and amygdala.Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortexSerotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development5-HT1A and 5-HT1B receptors differentially modulate rate and timing of auditory responses in the mouse inferior colliculus.Genetic variation in cortico-amygdala serotonin function and risk for stress-related diseaseThe serotonin releaser fenfluramine alters the auditory responses of inferior colliculus neurons.Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia.Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats.Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expressionDifferential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine.Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.Activity-dependent serotonergic excitation of callosal projection neurons in the mouse prefrontal cortex.GABA(B) receptor modulation of serotonin neurons in the dorsal raphé nucleus and escalation of aggression in mice.Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Neuron density and serotonin receptor binding in prefrontal cortex in suicide.Linking variability in brain chemistry and circuit function through multimodal human neuroimaging.In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations.Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): modifying serotonin's downstream effects on glutamate and GABA (gamma amino butyric acid) release.Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.Double and triple in situ hybridization for coexpression studies: combined fluorescent and chromogenic detection of neuropeptide Y (NPY) and serotonin receptor subtype mRNAs expressed at different abundance levels
P2860
Q24595389-D2CA4C35-904E-43C8-A849-F7E82B12109BQ24645913-6AB4C921-7046-40C4-89C1-F41DE92F55FCQ24646533-4369DB9E-502B-4930-B8EF-20D248591E9EQ26782933-520F76F5-BBC6-4045-83CB-77CA0971D1D6Q26799334-634A60A0-7978-4E02-92F5-B489CA12263BQ26851996-6AF73FFA-76CA-43B1-B9A8-98DE38EB1FA7Q26864503-B533505E-2D13-45F1-A34C-7361029785E8Q27007030-31D9803C-E789-44DD-A112-448BB5A01533Q27027381-C1BA2D5D-911C-4BF2-BD87-CD464B0E6D50Q28080944-81309B4D-469A-4DDE-AE11-FB8D33D6D05CQ28265440-11F83CD0-B378-4BA1-B351-F27898EC0F3DQ28273285-F4D29B42-3576-4505-8061-E9D27F1BFB76Q28281024-D11AEA4A-5AAA-4F55-855D-5703030A962FQ28485235-D476A80D-2B13-4D91-A564-62A0E97B1768Q28583582-9FA4B8CD-17B4-4EC0-9755-49910D2E036FQ28741999-EE5C3D63-E979-4573-91AE-F97F90FCB4DAQ30474638-5D8FDCBD-F741-4A67-8129-5E4380E8A55EQ30487278-BDEDEF98-1767-4F4F-9626-5F3AA4B3AC7FQ30494292-5ED85770-777C-4C3D-8811-D6325E419F0CQ30581184-35BB932A-3CDF-4B2F-9578-76F873C649D1Q30852008-FAC8AF8D-B415-419F-A593-6513E741764BQ31163228-DE8BC4FB-7DD1-43AB-8F61-45FD7F41B45CQ33719414-78D8073E-4644-4E09-A8C1-F7C04FF01E33Q33839517-52F52618-371C-412E-B362-4F09BC800B6BQ34020568-58CE1F7C-5762-478A-A5F9-B333731B3794Q34087741-C2420C2F-4ADC-4BB8-8484-E2736B1064D1Q34144878-4B27E251-858F-4892-A16B-386A122B6ADAQ34169978-87CB2221-DF9F-4553-B329-111B8550E3EEQ34205693-B16B78ED-DABB-42F4-BE2C-D9B996E1BE34Q34207360-154DF850-C580-45C6-A583-E47C4B3958B1Q34238841-CF40C7DB-3C65-428F-9755-2A9E14A2E6C5Q34253463-79831C68-9F5B-479A-B5C4-00422254677FQ34311721-55BD1DBD-48D2-443D-8841-7A810E1EB342Q34340909-5944DCC9-A628-4F92-866D-24FF94B2ED39Q34350194-48618331-CE00-4EE5-AE68-82E57928682EQ34417806-48BC7772-51BB-4BA4-9562-820E245B8CFCQ34519135-79B79BC4-2ED4-4CB2-AD26-C76C11B33787Q34670552-E1285197-A1EE-4DED-AAF8-D20F70EEE055Q35225923-AF3CC1EE-0DD7-490B-A857-F76135D7403CQ35644100-AA83B037-F040-4D44-BF73-6ED3EB8F5AEF
P2860
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@ast
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@en
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@nl
type
label
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@ast
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@en
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@nl
prefLabel
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@ast
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@en
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@nl
P2093
P50
P3181
P356
P1433
P1476
Co-expression and in vivo inte ...... l neurons of prefrontal cortex
@en
P2093
Analía Bortolozzi
Francesc Artigas
Jordi Serrats
Mercè Amargós-Bosch
Miklos Toth
Pau Celada
P304
P3181
P356
10.1093/CERCOR/BHG128
P407
P577
2004-03-01T00:00:00Z